Member Info for ogm4

5.20 p paid... off we go!

A "2" shows up over the RNS icon, but can't see it

2nd RNS logged ???

500+ trades so far...
sufficient interest

Indeed, we're not the only ones nearby:

Based on published literature, the Hawiah deposit appears analogous to the Al Masane polymetallic VMS mine in southern Saudi Arabia, with similar metal composition and structural and geological settings, (reported proven and probable reserves of 7.21mt at 1.42% Cu, 5.31% Zn, 1.19g/t Au and 40.2 g/t Ag which is approximately 400,000 tonnes contained copper-equivalent in situ).  To the north of Hawiah is another polymetallic VMS mine, Jabal Sayid, which is operated by Barrick Gold Corporation and Saudi Arabian Mining Company, Ma'aden, and is focused on the stockwork zone (reported proven and probable reserves of 27.11mt at 2.38% Cu being 650,000 tonnes contained copper in-situ).

KEFI anticipates Hawiah can be advanced to a development decision at relatively low cost due to the continuous nature of the mineralisation and, in due course, development funding will be readily available.  For example, KEFI not only has a strong partner in G&M but also the Saudi Industrial Development Fund provides loans for up to 75% of the capital cost of mine development at attractive interest rates.

Glad I was able to get in this morning well below 2p !...

Great top up opportunity today :-)

nice finish!!! bring on tomorrow!....

Looking at the chart it looks like TRX is ready for the next leg up...

from Friday

£30 and £31k popping up...

strange

takeover?...

9,350,194 shares in one single trade

from yesterday...

wow, another.massive trade!

many from yesterday as well

https://mobile.twitter.com/sharp_bj/status/1217499372096827392

Watch the late trades closely here, there is more than meets the eye !...

Yesterday so much money went around unbelievable, something is a foot.

Facility expansion
Tissue Regenix has received confirmation of a $0.3m grant from Universal City to support the commencement of the initial phase of the build out programme on the Company's newly leased 21,000 sq.ft. facility in San Antonio, further details of which were announced on 15 August 2019. This grant will assist and permit the upgrades of utilities and infrastructure serving the new facility.
Technical staff necessary to enable the second shift in the original San Antonio facility to become operational have been recruited and are in the process of being trained. Monthly processing throughput has already more than doubled in the year to Q3 and these additional products are expected to become available towards the end of Q4.
The Company is working closely with its existing outsource provider, CTS, in order to increase the yield of its DermaPure® product after also announcing the launch of DermaPure® Non-Oriented, for use in surgical and uro-gynaecology applications, at the American Urogynecologic Society conference in Nashville in September. The Company is working closely with its strategic partner, ARMS Medical, on the roll out of this product.

John Samuel, Executive Chairman, Tissue Regenix plc commented, "We have excellent products for which demand is exceeding our current capacity. Therefore, our current focus is ensuring we can increase our capacity to meet this significant demand."